Biocompounds Pharmaceutical Inc.

Biocompounds Pharmaceutical passes ISO three-system recertification audit

2025.03.31

Return Next：

21

2025.02

Anhui Biocompounds C

To further enhance employees' safety awareness, improve emer

Recently, following review and subsequent improvements by a third-party authoritative certification expert group, Biocompounds Pharmaceutical Inc. successfully passed the recertification audit for three major management systems: ISO 9001 Quality Management, ISO 14001 Environmental Management, and ISO 45001 Occupational Health and Safety Management.

This recertification was conducted by an expert team from an authoritative certification body. Through document review, on-site inspections, and personnel interviews, the team systematically assessed Biocompounds Pharmaceutical R&D center's quality control processes, environmental compliance management, and laboratory safety standards. The audit team highly praised Shanghai Beika's standardized management in areas such as the integrity of R&D data, waste classification standards, and occupational health risk prevention and control, concluding that its systems were rigorous and effective, met the standard requirements, and therefore approved the recertification audit.